Secondary outcomes of a behavioral sleep intervention: A randomized clinical trial.
Oxana Palesh(Virginia Commonwealth University), Karen M. Mustian(University of Rochester Medical Center), Bingjie Tong, Caroline Scheiber(Stanford University), Shelli R. Kesler(Livestrong Foundation), Richard Gevirtz(Alliant International University), Mallory G. Cases(Stanford University), Charles E. Heckler(University of Rochester Medicine), Nick G. Chrysson(National Cancer Centre Japan), Joseph J. Guido(Seagen (Canada)), Michelle C. Janelsins(University of Rochester), J. Martin Miller(Metro-Minnesota Community Oncology Research Consortium)
Cited by 19
Related Papers
Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
|Journal of Clinical Oncology|1999|960
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Applied Discriminant Analysis
|Technometrics|1995|409